P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

January 2005

Features

Healthcare and Law

Do We Need a Second FDA to Prevent Another COX-2 Fiasco?

If another agency, similar to the FDA, were created to handle postmarketing surveillance of drugs, would we be able to avoid recalls?
Robert I. Field, JD, MPH, PhD

The Role of Pharmacoeconomics in Formulary Management: Triptan Case Study for Migraine

The authors present the example of a triptan case study to help formulary decision-makers evaluate the cost-effectiveness of drugs within a category.
Mei-Jen Ho, PharmD, Vijay N. Joish, PhD, and Joseph E. Biskupiak, PhD, MBA

Meeting Highlights

44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Dr. Prescott reviews the use of azithromycin microspheres for acute exacerbation of chronic bronchitis; moxifloxacin for intra-abdominal infection; oseltamivir for reducing the risk of pneumonia; anidulafungin for HIV-negative patients with esophageal candidiasis; enfuvirtide; tipranavir and combination therapies for HIV infection; and peginterferon alfa-2a/ribavirin for HIV/hepatitis C co-infection.
Lawrence M. Prescott, PhD

Meeting Highlights

American Heart Association Scientific Sessions 2004

The author summarizes the benefits of an extended-release niacin/statin combination to slow atherosclerosis; telmisartan for hypertensive patients with the metabolic syndrome; a glucose–insulin infusion for acute myocardial infarction; tilarginine; a nitrate/diuretic for African-Americans with heart failure; isotope versus vasodilator therapy; rimonabant for weight loss; atorvastatin to delay Alzheimer’s disease; and a new marker (Lp-PLA2) for coronary artery disease.
Lawrence M. Prescott, PhD

Physician Participation in Clinical Studies and Subsequent Prescribing of New Drugs

The authors discuss the factors that influence physician-investigators to prescribe study drugs sooner and more often than physicians who are not involved in clinical trials.
Mark H. Corrigan, MD, and Harold E. Glass, PhD

Departments

Editorial

Mirror, Mirror

David B. Nash, MD, MBA, summarizes a 10-point strategy for moving the health care system in the right direction.
David B. Nash, MD, MBA

Prescription: Washington

The Flu Fix: Short-Term and Long-Term Changes Are Needed

Stephen Barlas uncovers some of the problems behind the 2004 flu vaccine shortage and suggests ways to prevent vaccine contamination.
Stephen Barlas

Medication Errors

For Better Understanding, All Patients Need Improved “Health Literacy”

Matthew Grissinger, RPh, FASCP, discusses ways to avoid errors by helping patients understand health information relating to their prescriptions and by helping them feel involved in their health care.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Atazanavir: A Once-Daily Protease Inhibitor for the Treatment of HIV-1 Infection

Drs. Vilme, Edwards, and McPherson-Baker review atazanavir for the treatment of HIV-1 infection.
Marie Vilme, PharmD, Deidree Edwards, PharmD, and Shvawn McPherson-Baker, PharmD, MPH, BCPS